Skip to main content
HEALIUS LIMITED logo

HEALIUS LIMITED — Investor Relations & Filings

Ticker · HLS ISIN · AU0000033359 LEI · 529900MBZK3SLWK8SJ55 ASX Human health and social work activities
Open in API
Filings indexed 2,292 across all filing types
Latest filing 2023-05-31 Share Issue/Capital Cha…
Country AU Australia
Listing ASX HLS

About HEALIUS LIMITED

https://www.healius.com.au

Healius Limited is a leading healthcare service provider specializing in pathology and diagnostic imaging services. The company operates an extensive network of pathology laboratories and collection centers, providing diagnostic testing across various medical disciplines including biochemistry, hematology, and microbiology. Its diagnostic imaging division offers a comprehensive range of services such as X-rays, ultrasounds, CT scans, and MRIs through a network of community-based and hospital-integrated clinics. Healius focuses on delivering high-quality diagnostic insights to healthcare professionals and patients, leveraging advanced technology and a large-scale infrastructure to support clinical decision-making and patient care outcomes.

Recent filings

Filing Released Lang Actions
Notification regarding unquoted securities - HLS 7 pages 29.7KB
Share Issue/Capital Change Classification · 95% confidence The document is a notification regarding the issue of unquoted equity securities under an employee incentive scheme by Healius Limited. It details the number and type of securities issued, dates, and mentions key management personnel involved. The document is a formal announcement of a securities issuance event, specifically unquoted securities, and includes references to ASX listing rules and exceptions. It does not contain financial statements, management discussion, or detailed financial results. It is not a full report but an announcement of a capital change event related to securities issuance. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and content support this classification with high confidence.
2023-05-31 English
Change of Director's Interest Notice 2 pages 238.7KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details the change in securities held by a director, including shares, options, and performance rights. The content focuses on the personal share transactions of a company director, including dates, number of securities before and after the change, and the nature of the change. There is no financial performance data, earnings information, or report publication details. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is 3029 characters, which is consistent with a detailed notice rather than a full report or announcement. Therefore, the correct classification is DIRS (Director's Dealing).
2023-05-31 English
Appointment of Group Executive, Healius Pathology 2 pages 122.2KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated 11 May 2023 regarding the appointment of a new Group Executive for Healius Pathology. It details the executive's background, the outgoing executive's transition, and the company's leadership structure. There is no financial data, no mention of financial results, no regulatory filings, no voting results, no legal proceedings, no capital changes, and no report publication. The content focuses solely on management changes at the executive level. Therefore, the document fits the category of Board/Management Information (MANG). The document length is 4335 characters, which is consistent with a typical management announcement rather than a full report or transcript.
2023-05-10 English
Update on DH sale, debt covenant waiver and consensus 2 pages 154.8KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 2 May 2023 from Healius Limited. It provides updates on the completion of the sale of Montserrat Day Hospitals, securing a debt covenant waiver, and confirmation of analyst underlying EBIT consensus for FY2023. The content focuses on corporate actions and financial covenant amendments rather than presenting full financial statements or detailed financial performance data. It is not a full annual or interim report, nor is it a transcript, audit report, or other detailed report type. The document is a corporate update announcement related to capital structure and operational changes. Therefore, it fits best under Capital/Financing Update (CAP). The document length is 4783 characters, which is sufficient for a substantive announcement but not a full report. Confidence is high given the clear focus on sale completion and debt covenant waiver.
2023-05-01 English
Notification of cessation of securities - HLS 4 pages 23.9KB
Regulatory Filings Classification · 95% confidence The document is a notification about the cessation of certain securities (options) for Healius Limited, detailing the number of securities that have ceased, the reason for cessation, and the updated issued capital following these changes. It is an announcement related to changes in the company's issued capital securities but does not describe a new share issue or capital increase. It is not a full financial report, earnings release, or management report. It is a regulatory announcement about securities ceasing to exist due to lapse of conditions. This fits best under Regulatory Filings (RNS) as it is a general regulatory announcement about securities status changes that do not fit into more specific categories like Share Issue/Capital Change (SHA) or Transaction in Own Shares (POS). The document length is short and it is a direct announcement, not a report publication or certification. Therefore, the classification is RNS with high confidence.
2023-05-01 English
Update on ASX waiver for issue of performance rights 1
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement regarding a waiver granted by the ASX to Healius Limited to issue performance rights under its Long Term Incentive Plan (LTIP). It discusses compliance with Listing Rules and the context of a takeover bid but does not contain financial statements, detailed financial data, or management discussion of results. The document is relatively short (2517 characters) and is an announcement about a capital issuance waiver rather than the issuance itself or a detailed report. Therefore, it fits best under Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2023-04-30 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.